Galderma Group AG (VIE:GALD)

Austria flag Austria · Delayed Price · Currency is EUR
160.00
+3.00 (1.91%)
At close: Feb 2, 2026
5.26%
Market Cap38.45B +38.8%
Revenue (ttm)3.99B +8.6%
Net Income321.87M
EPS1.35
Shares Outn/a
PE Ratio119.45
Forward PE46.03
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume3
Open157.00
Previous Close157.00
Day's Range157.00 - 160.00
52-Week Range149.00 - 180.00
Betan/a
RSI38.33
Earnings DateMar 5, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Industry Pharmaceutical Preparations
Founded 1981
Employees 6,545
Stock Exchange Vienna Stock Exchange
Ticker Symbol GALD
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements